About
Inreda Diabetic is a Dutch medical technology company based in Goor, Overijssel. The company specializes in developing a bi-hormonal artificial pancreas system that autonomously regulates blood glucose levels for individuals with type 1 diabetes. This fully automatic device continuously monitors blood glucose and administers insulin or glucagon as needed, eliminating the need for manual carbohydrate counting or insulin dose calculations. The artificial pancreas received CE marking in 2020, allowing it to be introduced to the European market. It has been utilized in pilot projects with Dutch health insurers and has treated over 125 patients in various hospitals. Early results show that more than 90% of users meet their treatment goals, leading to improved quality of life and increased daily activity. Inreda Diabetic emphasizes a people-centered approach, focusing on usability and comfort, while also working on further enhancements to the device for broader market adoption.
Technologies
Keywords
Company Information
-
Employees 57
-
Founded 2003
Location
Klavermaten, Goor, Overijssel, Netherlands
